Nutra Pharma Corp.'s Subsidary Designer Diagnostics Inc. Engages U.S. Commercial Service for International Growth
BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that its medical device subsidiary, Designer Diagnostics, has initiated a partnership with the U.S. Commercial Service to help build international sales of its diagnostic test kits.